With semaglutide patent ending, Indian pharma firms are set to launch lower-cost versions, prompting hospitals and clinics to expand obesity services ahead of a surge in demand.
Several leading Indian drugmakers have already secured regulatory approval or recommendations to produce and market generic versions of the weight loss drugs in India.
Children with certain genetic defects affecting hunger control can become severely obese from the age of one or two. Findings suggest that medicines based on GLP-1 hormone may work.
The ad by Lilly India is opening the door to a weight loss conversation. It features links to research papers from the World Health Organisation and Columbia University.
Study analysed data from over 540,000 adults in Finland and the UK. To study worldwide estimates, the researchers then used global data from the Global Burden of Diseases (GBD) Study.
These facilities have locked gates and perimeter fencing with huge walls on all sides, and no participant can willingly leave during the course unless they have a valid reason.
An enemy of brown fat is the AC3-AT protein—found within the fat itself—which can shut down brown fat’s activation and cancel out its calorie-burning benefits.
Modi reinforced his previous recommendations to address the crisis, urging families to purchase 10% less cooking oil, and reduce its consumption by the same margin on a regular basis.
Pharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and Wegovy, are expiring in nearly 100 nations.
His resignation letter alleged that practices within the bank were not in congruence with his personal values and ethics led to HDFC shares slumping to their lowest since June 2024.
Rating democracies is a tricky business. I am only using the simple metric of who in the Indian subcontinent has had the most peaceful, stable, normal political transitions and continuity.
COMMENTS